Hydroxyurea: Pattern of Use, Patient Adherence, and Safety Profile in Patients with Sickle Cell Disease in Oman

OBJECTIVES: Many barriers contribute to the underutilization of hydroxyurea (HU) in the treatment of sickle cell disease (SCD), and adherence to its use is often reported to be suboptimal. It is important to have information on the safety of HU in patients with SCD. Our study assessed the pattern of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jose, Jimmy, Elsadek, Refaat Abdullah, Jimmy, Beena, George, Prasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OMJ 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642718/
https://www.ncbi.nlm.nih.gov/pubmed/31360322
http://dx.doi.org/10.5001/omj.2019.64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642718/
https://www.ncbi.nlm.nih.gov/pubmed/31360322
http://dx.doi.org/10.5001/omj.2019.64

Ejemplares similares